ARMP Armata Pharmaceuticals Inc

USD 3.02 -0.28 -8.484848
Icon

Armata Pharmaceuticals Inc (ARMP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.02

-0.28 (-8.48)%

USD 0.12B

4.89K

USD 8.00(+164.90%)

N/A

Icon

ARMP

Armata Pharmaceuticals Inc (USD)
COMMON STOCK | NYE
USD 3.02
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.12B

N/A

USD 3.02

Armata Pharmaceuticals Inc (ARMP) Stock Forecast

Show ratings and price targets of :
USD 8.00
(+164.90%)

Based on the Armata Pharmaceuticals Inc stock forecast from 2 analysts, the average analyst target price for Armata Pharmaceuticals Inc is USD 8.00 over the next 12 months. Armata Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Armata Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Armata Pharmaceuticals Inc’s stock price was USD 3.02. Armata Pharmaceuticals Inc’s stock price has changed by +0.67% over the past week, +9.03% over the past month and +162.61% over the last year.

No recent analyst target price found for Armata Pharmaceuticals Inc
No recent average analyst rating found for Armata Pharmaceuticals Inc

Company Overview Armata Pharmaceuticals Inc

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's prod...Read More

5005 McConnell Avenue, Los Angeles, CA, United States, 90066

66

December

USD

USA

Adjusted Closing Price for Armata Pharmaceuticals Inc (ARMP)

Loading...

Unadjusted Closing Price for Armata Pharmaceuticals Inc (ARMP)

Loading...

Share Trading Volume for Armata Pharmaceuticals Inc Shares

Loading...

Compare Performance of Armata Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ARMP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Armata Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -5.43 (-4.01%) USD630.97B 48.58 4.92

ETFs Containing ARMP

Symbol Name ARMP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Armata Pharmaceuticals Inc (ARMP) Stock

Based on ratings from 2 analysts Armata Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on ARMP's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for ARMP is USD 8.00 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 7.

Unfortunately we do not have enough data on ARMP's stock to indicate if its overvalued.

The last closing price of ARMP's stock was USD 3.02.

The most recent market capitalization for ARMP is USD 0.12B.

Based on targets from 2 analysts, the average taret price for ARMP is projected at USD 8.00 over the next 12 months. This means that ARMP's stock price may go up by +164.90% over the next 12 months.

We can't find any ETFs which contains Armata Pharmaceuticals Inc's stock.

As per our most recent records Armata Pharmaceuticals Inc has 66 Employees.

Armata Pharmaceuticals Inc's registered address is 5005 McConnell Avenue, Los Angeles, CA, United States, 90066. You can get more information about it from Armata Pharmaceuticals Inc's website at https://www.armatapharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...